Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol and Neurodevelopmental Disorders in Children
Keith Cheung, Murray D. Mitchell, Helen Heussler
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Modulatory Effect of Gut Microbiota on the Gut-Brain, Gut-Bone Axes, and the Impact of Cannabinoids
Iddrisu Ibrahim, Soumyakrishnan Syamala, Joseph Ayariga, et al.
Metabolites (2022) Vol. 12, Iss. 12, pp. 1247-1247
Open Access | Times Cited: 31
A systematic review of cannabidiol trials in neurodevelopmental disorders
Nina-Francecsa Parrella, Aron T. Hill, Peter G. Enticott, et al.
Pharmacology Biochemistry and Behavior (2023) Vol. 230, pp. 173607-173607
Open Access | Times Cited: 18
Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment
Joseph Palumbo, Brian F. Thomas, Dejan B. Budimirovic, et al.
Journal of Neurodevelopmental Disorders (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Cannabis Pharmacogenomics: A Path to Personalized Medicine
Mariana Babayeva, Zvi G. Loewy
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3479-3514
Open Access | Times Cited: 16
Medical cannabis for children: Evidence and recommendations
Lauren E. Kelly, Michael Rieder, Yaron Finkelstein
Paediatrics & Child Health (2024) Vol. 29, Iss. 2, pp. 104-112
Open Access | Times Cited: 5
The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders
Anna Stasiłowicz-Krzemień, Wiktoria Nogalska, Zofia Maszewska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5749-5749
Open Access | Times Cited: 5
Cannabidiol attenuates lipid metabolism and induces CB1 receptor-mediated ER stress associated apoptosis in ovarian cancer cells
Xuanhe Fu, Zhixiong Yu, Fang Fang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Phenotypic variability to medication management: an update on fragile X syndrome
Nasser A. Elhawary, Imad A. AlJahdali, Iman S. Abumansour, et al.
Human Genomics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 10
Autism and associated disorders: cannabis as a potential therapy
Mariana Babayeva, Haregewein Assefa, Paramita Basu, et al.
Frontiers in Bioscience-Elite (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Restoring prefrontal cortical excitation-inhibition balance with cannabidiol ameliorates neurobehavioral abnormalities in a mouse model of neurodevelopmental disorders
Lu Zhang, Chunqiao Lin, Jiushuang Zhu, et al.
Neuropharmacology (2023) Vol. 240, pp. 109715-109715
Closed Access | Times Cited: 7
Quantification of 7 cannabinoids in cannabis oil using GC-MS: Method development, validation and application to therapeutic preparations in Friuli Venezia Giulia region, Italy
Martina Franzin, Rachele Ruoso, Rossella Del Savio, et al.
Heliyon (2023) Vol. 9, Iss. 4, pp. e15479-e15479
Open Access | Times Cited: 6
El papel de los cannabinoides en los trastornos del neurodesarrollo de niños y adolescentes
Francisca Freitas, Sofia Pimenta, Sara Soares, et al.
Revista de Neurología (2022) Vol. 75, Iss. 07, pp. 189-189
Open Access | Times Cited: 9
Neurotoxicity and neuroprotection induced by plant-derived cannabinoids
Marilyn Silva
Elsevier eBooks (2024), pp. 831-873
Closed Access | Times Cited: 1
A Potential Drug-Gene-Drug Interaction Between Cannabidiol, CYP2D6*4, and Fluoxetine
Lyndsey L. Anderson, Jonathon C. Arnold, Iain S. McGregor, et al.
Journal of Clinical Psychopharmacology (2022) Vol. 42, Iss. 4, pp. 422-424
Closed Access | Times Cited: 7
Characterisation of ReNcells CX and VM stimulated with interleukin-1β and lipopolysaccharide
Keith Cheung, Pevindu Abeysinghe, Kanchan Vaswani, et al.
Neurochemistry International (2022) Vol. 156, pp. 105326-105326
Closed Access | Times Cited: 3
Les données probantes et les recommandations sur le cannabis à des fins médicales chez les enfants
Lauren E. Kelly, Michael Rieder, Yaron Finkelstein
Paediatrics & Child Health (2024) Vol. 29, Iss. 2, pp. 113-121
Open Access
Factors for Implementing Medical Cannabis Cultivation in Brazil
Danielle L. de Oliveira, Ana Cláudia F. Amaral, Aline de Souza Ramos
The Natural Products Journal (2024) Vol. 15, Iss. 2
Closed Access
Implication of the endocannabidiome and metabolic pathways in fragile X syndrome pathophysiology
Olivier Dionne, Armita Abolghasemi, François Corbin, et al.
Psychiatry Research (2024) Vol. 337, pp. 115962-115962
Open Access
Cannabis Compounds: Potential Therapy for Neurological Disease
Mariana Babayeva, Zvi G. Loewy
IntechOpen eBooks (2024)
Open Access
Principais alvos farmacológicos e potencial terapêutico do canabidiol (CDB)
Ana Beatriz Monteiro de Medeiros, Laíza Andrade Soares Diniz, Aarão Gonçalves de Lira, et al.
Caderno Pedagógico (2024) Vol. 21, Iss. 9, pp. e7673-e7673
Closed Access
Transtorno do Espectro Autista: uso da cannabis em pacientes pediátricos
Luiz Eduardo Matoso Freire, Giovana Montenegro Amorim Gomes, Ingrid Letícia Torres Fabrício, et al.
RAMB Revista da Associação Médica Brasileira Junior Doctors (2024) Vol. 5, Iss. 2, pp. 77-82
Closed Access
Etiology and Translational Research in Neurodevelopmental Disorders
Fei Li, Mingyu Xu, Juehua Yu, et al.
(2024), pp. 19-36
Closed Access
Neurotoxic or Protective Cannabis Components: Delta-9-Tetrahydrocannabinol (Δ9THC) and Cannabidol (CBD)
Marilyn Silva
Journal of Exploratory Research in Pharmacology (2023) Vol. 8, Iss. 4, pp. 299-322
Open Access | Times Cited: 1
PACIENTES NEUROPSIQUIÁTRICOS E OS BENEFÍCIOS DO TRATAMENTO COM FITOCANABINÓIDES
Maria Carolina Rodrigues De Oliveira, Gabriela Fernandes Zauza, Wilson Paes De Oliveira Júnior, et al.
Arquivos de Ciências da Saúde da UNIPAR (2023) Vol. 27, Iss. 8, pp. 4537-4559
Open Access | Times Cited: 1
The Neurobiology of Prader-Willi Syndrome
Deepan Singh
Cambridge University Press eBooks (2022), pp. 154-170
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top